Form D · Biotechnology
CanDiag, Inc.
Charlotte, NC · CIK 0001558456
Offering snapshot reported Sep 11, 2013 · SEC filing
- Reported sold
- $461K Offering amount: $1.38M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 11, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 11, 2013 | Initial | $461,000 | No comparison | 4 | SEC filing |
| Jan 23, 2013 | Amendment | $570,502 | $30,000vs Oct 12, 2012 | 8 | SEC filing |
| Oct 12, 2012 | Initial | $540,502 | No comparison | 8 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-202675
Source: Form D, filed Sep 11, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Pinku Mukherjee, Ph.D. | Director, Executive |
| Rahul Puri | Director |
| Taffy Williams, Ph.D. | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
Bioinformatics Building, Room 243 9201 University City Boulevard
Charlotte, NC, 28223
Charlotte, NC, 28223